Shattuck Labs

STTK · NASDAQ

$5.84+$0.47 (+8.75%)TodayMarket closed ·
Prev close $5.37

Latest news

  • Press releaseGlobe Newswire

    Shattuck Labs Announces Phase 2 Clinical Trial of SL-325 in Hidradenitis Suppurativa and Appointment of Shoba Ravichandran, M.D., as Senior Vice President, Clinical Development

  • Press releaseGlobe Newswire

    Shattuck Labs Reports Second Quarter 2026 Financial Results and Recent Business Highlights

  • Press releaseGlobe Newswire

    Shattuck Labs Announces Exercise of Outstanding Common Stock Warrants and Provides Financial Update

  • NewsVandana Singh

    Why Is Shattuck Labs Stock Trading Lower On Monday?

  • NewsAvi Kapoor

    Crude Oil Gains Over 1%; Motorcar Parts Of America Shares Surge After Q4 Earnings

  • Press releaseGlobe Newswire

    Shattuck Labs Announces Phase 1 Results for SL-325

  • NewsAvi Kapoor

    Concrete Pumping Holdings Reports Blowout Q2 Results, Joins ServiceTitan and Other Big Stocks Moving Higher in Friday's Pre-Market Session

  • Press releaseGlobe Newswire

    Shattuck Labs Reports First Quarter 2026 Financial Results and Recent Business Highlights

  • News

    12 Health Care Stocks Moving In Wednesday's After-Market Session

  • News

    Insights into Shattuck Labs Q4 Earnings

  • Press releaseGlobe Newswire

    Shattuck Labs Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Business Highlights

  • Press releaseGlobe Newswire

    Shattuck Labs Reports Third Quarter 2025 Financial Results and Recent Business Highlights

  • Press releaseGlobe Newswire

    Shattuck Labs Announces Closing of up to $103 Million Private Placement and Appointments to Board of Directors

  • Press releaseGlobe Newswire

    Shattuck Labs Announces IND for SL-325 Is in Effect for the Treatment of Inflammatory Bowel Disease

  • Press releaseGlobe Newswire

    Shattuck Labs Reports Second Quarter 2025 Financial Results and Recent Business Highlights

  • News

    12 Health Care Stocks Moving In Tuesday's Intraday Session

  • NewsAvi Kapoor

    Dow Surges Over 100 Points; Pfizer Earnings Top Views

  • News

    12 Health Care Stocks Moving In Tuesday's Pre-Market Session

  • Press releaseGlobe Newswire

    Shattuck Labs Reports First Quarter 2025 Financial Results and Recent Business Highlights

  • NewsAvi Kapoor

    Why Levi Strauss Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket

  • Press releaseGlobe Newswire

    Shattuck Labs Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Highlights

  • Press releaseGlobe Newswire

    Shattuck Labs Provides Corporate Update and Highlights Upcoming Key Milestones in 2025

  • Press releasePRNewswire

    SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Shattuck Labs, Inc. - STTK

  • Press releasePRNewswire

    SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Shattuck Labs, Inc. - STTK

  • Press releaseBusiness Wire

    STTK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Shattuck Labs, Inc. and Encourages Investors to Contact the Firm

  • Press releaseBusiness Wire

    STTK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Shattuck Labs, Inc. and Encourages Investors to Contact the Firm

  • Press releaseGlobe Newswire

    STTK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Shattuck Labs, Inc. and Encourages Investors to Contact the Firm

  • Press releasePRNewswire

    SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Shattuck Labs, Inc. - STTK

  • Press releaseGlobe Newswire

    STTK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Shattuck Labs, Inc. and Encourages Investors to Contact the Firm

  • Press releasePRNewswire

    STTK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Shattuck Labs, Inc. and Encourages Investors to Contact the Firm

  • Press releaseGlobe Newswire

    STTK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Shattuck Labs, Inc. and Encourages Investors to Contact the Firm

  • News

    Shattuck Labs Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)

  • News

    Assessing Shattuck Labs: Insights From 7 Financial Analysts

  • Press releaseGlobe Newswire

    Shattuck Labs Reports Second Quarter 2024 Financial Results and Recent Business Highlights

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.